175 related articles for article (PubMed ID: 25834670)
1. Characteristics of patients that do not initially respond to intravenous antihypertensives in the emergency department: subanalysis of the CLUE trial.
Freiermuth CE; Chandra A; Peacock WF;
West J Emerg Med; 2015 Mar; 16(2):276-83. PubMed ID: 25834670
[TBL] [Abstract][Full Text] [Related]
2. Impact of initial blood pressure on antihypertensive response in patients with acute hypertension.
Farias S; Peacock WF; Gonzalez M; Levy PD
Am J Emerg Med; 2014 Aug; 32(8):833-6. PubMed ID: 24857251
[TBL] [Abstract][Full Text] [Related]
3. Continuous-Infusion Labetalol vs Nicardipine for Hypertension Management in Stroke Patients.
Hecht JP; Richards PG
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):460-465. PubMed ID: 29092768
[TBL] [Abstract][Full Text] [Related]
4. Time to Blood Pressure Control Before Thrombolytic Therapy in Patients With Acute Ischemic Stroke: Comparison of Labetalol, Nicardipine, and Hydralazine.
McKay C; Hall AB; Cortes J
J Neurosci Nurs; 2015 Dec; 47(6):327-32. PubMed ID: 26528950
[TBL] [Abstract][Full Text] [Related]
5. The management of acute hypertension in patients with renal dysfunction: labetalol or nicardipine?
Varon J; Soto-Ruiz KM; Baumann BM; Borczuk P; Cannon CM; Chandra A; Cline DM; Diercks DB; Hiestand B; Hsu A; Jois-Bilowich P; Kaminski B; Levy P; Nowak RM; Schrock JW; Peacock WF
Postgrad Med; 2014 Jul; 126(4):124-30. PubMed ID: 25141250
[TBL] [Abstract][Full Text] [Related]
6. CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department.
Peacock WF; Varon J; Baumann BM; Borczuk P; Cannon CM; Chandra A; Cline DM; Diercks D; Hiestand B; Hsu A; Jois-Bilowich P; Kaminski B; Levy P; Nowak RM; Schrock JW
Crit Care; 2011; 15(3):R157. PubMed ID: 21707983
[TBL] [Abstract][Full Text] [Related]
7. Comparative prophylactic and therapeutic effects of intravenous labetalol 0.4 mg/kg and nicardipine 20 μg/kg on hypertensive responses to endotracheal intubation in patients undergoing elective surgeries with general anesthesia: a prospective, randomized, double-blind study.
Ryu JH; Apfel CC; Whelan R; Jeon YT; Hwang JW; Do SH; Ro YJ; Kim CS
Clin Ther; 2012 Mar; 34(3):593-604. PubMed ID: 22364823
[TBL] [Abstract][Full Text] [Related]
8. A prospective evaluation of labetalol versus nicardipine for blood pressure management in patients with acute stroke.
Liu-DeRyke X; Levy PD; Parker D; Coplin W; Rhoney DH
Neurocrit Care; 2013 Aug; 19(1):41-7. PubMed ID: 23760911
[TBL] [Abstract][Full Text] [Related]
9. Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial.
Cannon CM; Levy P; Baumann BM; Borczuk P; Chandra A; Cline DM; Diercks DB; Hiestand B; Hsu A; Jois P; Kaminski B; Nowak RM; Schrock JW; Varon J; Peacock WF
BMJ Open; 2013 Mar; 3(3):. PubMed ID: 23535700
[TBL] [Abstract][Full Text] [Related]
10. Intravenous labetalol compared with intravenous nicardipine in the management of hypertension in critically ill patients.
Malesker MA; Hilleman DE
J Crit Care; 2012 Oct; 27(5):528.e7-14. PubMed ID: 22300487
[TBL] [Abstract][Full Text] [Related]
11. A comparison of nicardipine and labetalol for acute hypertension management following stroke.
Liu-Deryke X; Janisse J; Coplin WM; Parker D; Norris G; Rhoney DH
Neurocrit Care; 2008; 9(2):167-76. PubMed ID: 18250979
[TBL] [Abstract][Full Text] [Related]
12. Blood Pressure Control in Acute Stroke: Labetalol or Nicardipine?
El-Ghoroury H; Sudekum DM; Hecht JP
J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105959. PubMed ID: 34217067
[TBL] [Abstract][Full Text] [Related]
13. Delay to Tissue Plasminogen Activator in Hypertensive Stroke Patients: An Analysis of Delay Duration Across Agents.
Carrera JF; Sorace BJ; Worrall BB; Southerland AM; Chiota-McCollum NA
J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104525. PubMed ID: 31812455
[TBL] [Abstract][Full Text] [Related]
14. Retrospective evaluation of nicardipine versus labetalol for blood pressure control in aneurysmal subarachnoid hemorrhage.
Woloszyn AV; McAllen KJ; Figueroa BE; DeShane RS; Barletta JF
Neurocrit Care; 2012 Jun; 16(3):376-80. PubMed ID: 22528277
[TBL] [Abstract][Full Text] [Related]
15. Nicardipine Reduces Blood Pressure Variability After Spontaneous Intracerebral Hemorrhage.
Poyant JO; Kuper PJ; Mara KC; Dierkhising RA; Rabinstein AA; Wijdicks EFM; Ritchie BM
Neurocrit Care; 2019 Feb; 30(1):118-125. PubMed ID: 30051193
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of nicardipine vs labetalol for the management of hypertensive crises.
Peacock WF; Hilleman DE; Levy PD; Rhoney DH; Varon J
Am J Emerg Med; 2012 Jul; 30(6):981-93. PubMed ID: 21908132
[TBL] [Abstract][Full Text] [Related]
17. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial.
Raheem IA; Saaid R; Omar SZ; Tan PC
BJOG; 2012 Jan; 119(1):78-85. PubMed ID: 21985500
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of nicardipine and labetalol infusion for blood pressure management in patients with intracerebral and subarachnoid hemorrhage.
Ortega-Gutierrez S; Thomas J; Reccius A; Agarwal S; Lantigua H; Li M; Carpenter AM; Mayer SA; Schmidt JM; Lee K; Claassen J; Badjatia N; Lesch C
Neurocrit Care; 2013 Feb; 18(1):13-9. PubMed ID: 23055089
[TBL] [Abstract][Full Text] [Related]
19. Effects of nicardipine and labetalol on the acute hemodynamic response to electroconvulsive therapy.
Avramov MN; Stool LA; White PF; Husain MM
J Clin Anesth; 1998 Aug; 10(5):394-400. PubMed ID: 9702620
[TBL] [Abstract][Full Text] [Related]
20. Nicardipine Associated Risk of Short-Term Mortality in Critically Ill Patients with Ischemic Stroke.
Sadeghi M; Saber H; Singh A; Hanni C; Parker D; Desai A; Mohamed W
J Stroke Cerebrovasc Dis; 2019 May; 28(5):1168-1172. PubMed ID: 30683492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]